Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. It offers medical cannabis oils, which includes cannabidiol drops, tetrahydrocannabinol drops, and mixture of CBD and THC oils. The company was founded by Thomas Skovlund Schnegelsberg, Soren Kjaer, and Rolf Steno Peterson on October 19, 2017 and is headquartered in Randers, Denmark.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company